Current stage-Stage I - Page 2 of 20 Posts on Medivizor
Navigation Menu

Current stage-Stage I Posts on Medivizor

Does the histological grade of early stage breast cancer effect outcomes of older women treated with breast conserving surgery?

Does the histological grade of early stage breast cancer effect outcomes of older women treated with breast conserving surgery?

Posted by on Jan 31, 2021 in Breast cancer | 0 comments

In a nutshell This article was carried out to look at how histological grade (HG) impacts the outcomes of older women with early-stage (ES) breast cancer (BC) treated with breast-conserving therapy (BCS) with or without radiotherapy (RT). The authors found that the treatment of ESBC without RT resulted in a lower cancer-specific survival...

Read More

Looking for patients with breast reconstructions following breast surgery to trial a short radiation therapy

Looking for patients with breast reconstructions following breast surgery to trial a short radiation therapy

Posted by on Jan 28, 2021 in Breast cancer | 0 comments

In a nutshell This trial is looking to examine the use of radiation on a shorter schedule of 5 days in a row is a safe and effective way to prevent breast cancer (BC) from coming back in people who have had a mastectomy (surgical removal of the breast). The main outcomes that are to be measured are local and regional disease recurrence. This trial is to...

Read More

Intensity-modulated radiation therapy with simultaneously integrated boost leads to shorter treatment time with similar outcomes as conventional radiotherapy after surgery for breast cancer

Intensity-modulated radiation therapy with simultaneously integrated boost leads to shorter treatment time with similar outcomes as conventional radiotherapy after surgery for breast cancer

Posted by on Jan 2, 2021 in Breast cancer | 0 comments

In a nutshell This study compared the effects of intensity-modulated radiation therapy (IMRT) with a simultaneously integrated boost (SIB) to conventional radiotherapy (CRT) with a sequential boost (SeqB) following breast-conserving surgery (BCS) in patients with breast cancer. The data showed that both radiotherapy techniques...

Read More

Chemotherapy improves triple-negative breast cancer survival in older women

Chemotherapy improves triple-negative breast cancer survival in older women

Posted by on Dec 27, 2020 in Breast cancer | 0 comments

In a nutshell This study looked at the outcomes of older women with triple-negative breast cancer who received chemotherapy before or after local treatment. The data showed that chemotherapy can be considered in the treatment of these patients. Some background Triple-negative breast cancer (TNBC) is a subtype of breast cancer (BC) that tests...

Read More

Comparing long-term outcomes of whole or partial breast irradiation after breast-conserving surgery

Comparing long-term outcomes of whole or partial breast irradiation after breast-conserving surgery

Posted by on Dec 13, 2020 in Breast cancer | 0 comments

In a nutshell This study compared whole breast irradiation (WBI) to partial breast irradiation (PBI) following breast-conserving surgery (BCS) in patients with low-risk breast cancer. The study showed similar survival between the 2 treatments, while PBI gave better cosmetic results. Some background Patients with low-risk breast...

Read More

Which is safer for the heart: tamoxifen or letrozole?

Which is safer for the heart: tamoxifen or letrozole?

Posted by on Nov 30, 2020 in Breast cancer | 0 comments

In a nutshell This study compared the safety of two hormonal medications used to treat breast cancer, tamoxifen (Nolvadex) and letrozole (Femara). This study found that tamoxifen was associated with an increased risk of blood clots, while letrozole was associated with an increased risk of angina and heart attacks. Some background Hormone-positive...

Read More

Irinotecan combined with capecitabine-based chemoradiotherapy before surgery improves the outcomes of patients with rectal cancer

Irinotecan combined with capecitabine-based chemoradiotherapy before surgery improves the outcomes of patients with rectal cancer

Posted by on Nov 29, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of treatment with irinotecan (Camptosar) combined with capecitabine (Xeloda) chemotherapy (ICC) before rectal cancer surgery. Researchers suggested that this combined therapy significantly improved the treatment outcomes in these patients. Some background Rectal cancer is a common...

Read More

Evaluating timing between chemoradiotherapy and surgery in patients with rectal cancer.

Evaluating timing between chemoradiotherapy and surgery in patients with rectal cancer.

Posted by on Nov 15, 2020 in Colorectal cancer | 0 comments

In a nutshell This trial was carried out to examine the optimal time interval between completing chemoradiotherapy (CRT) and robotic-assisted surgery (RAS) in patients with rectal cancer. The trial found that RAS is safe and effective after 10-12 weeks of CRT. Some background Rectal cancer treatment has experienced an improvement with new...

Read More

Predicting response to 10 years of endocrine therapy in patients with hormone receptor positive early stage breast cancer

Predicting response to 10 years of endocrine therapy in patients with hormone receptor positive early stage breast cancer

Posted by on Nov 15, 2020 in Breast cancer | 0 comments

In a nutshell The study evaluated whether Breast Cancer Index (BCI) can predict benefits from extended endocrine therapy (EET) in patients with hormone-receptor-positive (HR+) early-stage breast cancer (BC). The authors found that BCI can predict which patients would benefit from 10 years of EET. Some background Endocrine therapy (ET) prevents tumor...

Read More

Comparing breast-conserving surgery and breast-removal surgery after chemotherapy in patients with breast cancer

Comparing breast-conserving surgery and breast-removal surgery after chemotherapy in patients with breast cancer

Posted by on Nov 5, 2020 in Breast cancer | 0 comments

In a nutshell This study compared the effectiveness of breast-conserving surgery (BCS) to mastectomy (breast-removal surgery) after chemotherapy in patients with breast cancer. The authors found that BCS does not result in a lower survival in these patients. Some background BC is one of the most common forms of cancer in women. Standard care...

Read More

Investigating the effectiveness of the treatment combination atezolizumab with chemotherapy before surgery for early triple negative breast cancer

Investigating the effectiveness of the treatment combination atezolizumab with chemotherapy before surgery for early triple negative breast cancer

Posted by on Oct 11, 2020 in Breast cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety of atezolizumab (Tecentriq) as an addition to chemotherapy before surgery for patients with early-stage triple-negative breast cancer (TNBC). The data showed that the combination is effective in improving treatment response in these patients. Some background...

Read More